INT MEDICAL (01501) announced that, as of 28 February 2026, its H share capital remained at 139.41 million shares with a par value of RMB1 each, and its domestic share capital stood at 71.79 million shares at the same par value. The total issued share capital amounted to RMB211.20 million. The filing confirms no changes in the number of H shares and domestic shares during the reporting period, and no treasury shares were held. The company also stated that its public float remains in compliance with the 25.00% threshold requirement.